A detailed history of Mission Wealth Management, LP transactions in Biogen Inc. stock. As of the latest transaction made, Mission Wealth Management, LP holds 2,067 shares of BIIB stock, worth $359,223. This represents 0.01% of its overall portfolio holdings.

Number of Shares
2,067
Previous 1,913 8.05%
Holding current value
$359,223
Previous $443,000 9.71%
% of portfolio
0.01%
Previous 0.01%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$189.07 - $236.8 $29,116 - $36,467
154 Added 8.05%
2,067 $400,000
Q2 2024

Aug 02, 2024

BUY
$190.52 - $236.72 $16,575 - $20,594
87 Added 4.76%
1,913 $443,000
Q1 2024

Apr 30, 2024

BUY
$212.02 - $267.71 $13,993 - $17,668
66 Added 3.75%
1,826 $393,000
Q4 2023

Feb 05, 2024

SELL
$222.59 - $267.94 $3,561 - $4,287
-16 Reduced 0.9%
1,760 $455,000
Q3 2023

Oct 23, 2023

BUY
$253.3 - $285.89 $46,607 - $52,603
184 Added 11.56%
1,776 $456,000
Q2 2023

Aug 04, 2023

SELL
$275.25 - $318.06 $825 - $954
-3 Reduced 0.19%
1,592 $453,000
Q1 2023

Apr 07, 2023

BUY
$256.56 - $292.34 $6,670 - $7,600
26 Added 1.66%
1,595 $443,000
Q4 2022

Feb 02, 2023

BUY
$252.44 - $306.72 $16,156 - $19,630
64 Added 4.25%
1,569 $434,000
Q3 2022

Oct 12, 2022

SELL
$194.69 - $268.46 $7,398 - $10,201
-38 Reduced 2.46%
1,505 $402,000
Q2 2022

Jul 27, 2022

SELL
$187.54 - $223.02 $18,191 - $21,632
-97 Reduced 5.91%
1,543 $315,000
Q1 2022

Apr 25, 2022

SELL
$193.77 - $244.14 $30,228 - $38,085
-156 Reduced 8.69%
1,640 $345,000
Q4 2021

Feb 11, 2022

BUY
$223.92 - $287.77 $402,160 - $516,834
1,796 New
1,796 $431,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Mission Wealth Management, LP Portfolio

Follow Mission Wealth Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mission Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Mission Wealth Management, LP with notifications on news.